Literature DB >> 9480881

Intracellular but not extracellular conversion of nitroxyl anion into nitric oxide leads to stimulation of human neutrophil migration.

B E Vanuffelen1, J Van Der Zee, B M De Koster, J Vansteveninck, J G Elferink.   

Abstract

Considerable controversy exists in the literature with regard to the nature of the agent mediating the biological effects of nitroxyl (NO-) donors. Here it is demonstrated that Angeli's salt (AS), a generator of NO-, enhanced human neutrophil migration. Under aerobic conditions, AS was converted to peroxynitrite to a small extent. However, using methionine, a scavenger of peroxynitrite, it was shown that peroxynitrite was not involved in AS-induced migration. AS equally enhanced human neutrophil migration under aerobic and anaerobic conditions, which strongly suggests that extracellular conversion of NO- to .NO by oxygen was not required. Furthermore, metHb and L-cysteine, which react more readily with NO- than with .NO, inhibited AS-induced migration, whereas the response towards gaseous .NO remained unaffected. AS induced an increase in the intracellular level of cGMP, although the curves for migration and cGMP level appeared to be slightly different in their concentration dependence. An inhibitor of soluble guanylate cyclase and antagonists of cGMP-dependent protein kinase had a more pronounced inhibitory effect on .NO-induced migration than on AS-induced migration. This suggests that the cGMP signalling cascade is partially, but not solely, responsible for AS-induced migration. As it has been demonstrated that soluble guanylate cyclase can only be activated by .NO, and not by NO-, these data indicate that NO- is at least partly converted intracellularly to .NO.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9480881      PMCID: PMC1219196          DOI: 10.1042/bj3300719

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

Review 1.  The nitric oxide and cGMP signal transduction system: regulation and mechanism of action.

Authors:  H H Schmidt; S M Lohmann; U Walter
Journal:  Biochim Biophys Acta       Date:  1993-08-18

2.  Glutathione-induced enhancement of neutrophil locomotion.

Authors:  J G Elferink; B M de Koster
Journal:  Immunobiology       Date:  1991-12       Impact factor: 3.144

3.  No .NO from NO synthase.

Authors:  H H Schmidt; H Hofmann; U Schindler; Z S Shutenko; D D Cunningham; M Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

4.  Endothelium-derived relaxing factor released from canine femoral artery by acetylcholine cannot be identified as free nitric oxide by electron paramagnetic resonance spectroscopy.

Authors:  S S Greenberg; D E Wilcox; G M Rubanyi
Journal:  Circ Res       Date:  1990-12       Impact factor: 17.367

5.  Alkaline Bohr effect of human hemoglobin Ao.

Authors:  E Di Cera; M L Doyle; S J Gill
Journal:  J Mol Biol       Date:  1988-04-05       Impact factor: 5.469

6.  The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor.

Authors:  J M Fukuto; K Chiang; R Hszieh; P Wong; G Chaudhuri
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

7.  Reaction of nitric oxide with heme proteins and model compounds of hemoglobin.

Authors:  V S Sharma; T G Traylor; R Gardiner; H Mizukami
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

Review 8.  Biochemistry of nitric oxide and its redox-activated forms.

Authors:  J S Stamler; D J Singel; J Loscalzo
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

9.  Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite.

Authors:  J S Beckman; H Ischiropoulos; L Zhu; M van der Woerd; C Smith; J Chen; J Harrison; J C Martin; M Tsai
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

10.  Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase.

Authors:  M E Murphy; H Sies
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  16 in total

Review 1.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

2.  Protein disulfide-isomerase mediates delivery of nitric oxide redox derivatives into platelets.

Authors:  Susannah E Bell; Chirag M Shah; Michael P Gordge
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

Review 3.  The specificity of nitroxyl chemistry is unique among nitrogen oxides in biological systems.

Authors:  Wilmarie Flores-Santana; Debra J Salmon; Sonia Donzelli; Christopher H Switzer; Debashree Basudhar; Lisa Ridnour; Robert Cheng; Sharon A Glynn; Nazareno Paolocci; Jon M Fukuto; Katrina M Miranda; David A Wink
Journal:  Antioxid Redox Signal       Date:  2011-03-16       Impact factor: 8.401

4.  Nitric oxide influences injury-induced microglial migration and accumulation in the leech CNS.

Authors:  A Chen; S M Kumar; C L Sahley; K J Muller
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

Review 5.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

6.  Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury.

Authors:  X L Ma; F Gao; G L Liu; B L Lopez; T A Christopher; J M Fukuto; D A Wink; M Feelisch
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

7.  Alterations in acetylcholinesterase and butyrylcholinesterase activities in chronic obstructive pulmonary disease: relationships with oxidative and inflammatory markers.

Authors:  Amel Ben Anes; Hela Ben Nasr; Abdelhamid Garrouch; Sarra Bennour; Sarra Bchir; Mohamed Hachana; Mohamed Benzarti; Zouhair Tabka; Karim Chahed
Journal:  Mol Cell Biochem       Date:  2017-12-12       Impact factor: 3.396

8.  Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt.

Authors:  A Ellis; H Lu; C G Li; M J Rand
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

9.  Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin.

Authors:  Steven B Solomon; Landon Bellavia; Daniel Sweeney; Barbora Piknova; Andreas Perlegas; Christine C Helms; Gabriela A Ferreyra; S Bruce King; Nicolaas J H Raat; Steven J Kern; Junfeng Sun; Linda C McPhail; Alan N Schechter; Charles Natanson; Mark T Gladwin; Daniel B Kim-Shapiro
Journal:  Free Radic Biol Med       Date:  2012-10-23       Impact factor: 7.376

10.  Kinetic feasibility of nitroxyl reduction by physiological reductants and biological implications.

Authors:  Matthew I Jackson; Tae H Han; Laura Serbulea; Andrew Dutton; Eleonora Ford; Katrina M Miranda; K N Houk; David A Wink; Jon M Fukuto
Journal:  Free Radic Biol Med       Date:  2009-07-02       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.